Schott, Alpha Innotech, Genomic Solutions Form Unofficial Co-Marketing Alliance | GenomeWeb

BOSTON, Sept. 15 (GenomeWeb News) - German slide and microtiter plate vendor Schott-Nexterion has teamed up with Genomic Solutions and Alpha Innotech to form an "unofficial collaboration" that enables the three companies to fuse their products in presentations to customers as "an integrated [product offering] for doing multiplexed assays," officials from the three firms said yesterday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.